ClinicalTrials.gg
Sign In

Lymphopenia clinical trials

The registry lists 44 studies for Lymphopenia across more than 10 countries. 8 are recruiting or about to start. 9 of them are mainly about Lymphopenia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its narrower condition Wiskott-Aldrich Syndrome too: 85 studies, 11 open.

Get an email when these change. Save the Lymphopenia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
18
Terminated
9
Recruiting
6
Status unknown
3
Active, not recruiting
3
Withdrawn
3

Phase

Phase 2
15
Phase 1
5
Phase 3
2
Early Phase 1
1

Where

United States
15
France
10
China
6
Italy
2
Turkey
2
Belgium
1

Who runs them

Revimmune (6) · ImmunityBio, Inc. (4) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Centre Leon Berard (2) · TRPHARM (2) · Second Affiliated Hospital of Soochow University (2) · Hospices Civils de Lyon (2) · Centre Hospitalier Universitaire de Saint Etienne (2)

What is being tested here

Drugs under test in Lymphopenia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nogapendekin alfa inbakicept112
Thymalfasin102
Aldesleukin101
Interleukin-2101
Interleukin 7009
Temozolomide001
Bempegaldesleukin001
Niacinamide001
Talfirastide001
Fingolimod001

Coming up

1phase 3 study under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 6 Lymphopenia studies recruiting now, 5 (83%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
186 (100%)6 (100%)
306 (100%)6 (100%)
406 (100%)6 (100%)
506 (100%)6 (100%)
656 (100%)6 (100%)
756 (100%)6 (100%)
856 (100%)6 (100%)

Across all 44 studies, recruiting or not: 7% stop at 75 or younger and 7% at 65; 11% take children; 5% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 44 of 44. search them.